Interasma Global Asthma Association

Category Archives: Other Publications

Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform

Anna Schultze, PhD *Alex J Walker, PhD *Brian MacKenna, MPharm *Caroline E Morton, MBChB *Prof Krishnan Bhaskaran, PhDJeremy P Brown, MScChristopher T Rentsch, PhDElizabeth Williamson, PhDHenry Drysdale, MRCSRichard Croker, MScSeb Bacon, BAWilliam Hulme, PhDChris…

Beliefs and preferences regarding biological treatments for severe asthma

World Allergy Organ J. 2020 Jul; 13(7): 100441. Published online 2020 Jul 31. doi: 10.1016/j.waojou.2020.100441 Andras Bikov,a,bIpek Kivilcim Oğuzülgen,cIlaria Baiardini,dMarco Contoli,eAlexander Emelyanov,fOmar Fassio,gJuan Carlos Ivancevich,hIgor Kaidashev,iKrzysztof Kowal,jMarina Labor,k,lLies Lahousse,mStefan Mihaicuta,nSilviya Novakova,oAlicia Padilla…

Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator

Research – Open Access Eulalia Jimenez, Carol Astbury, Muna Albayaty, Ulrika Wählby-Hamrén, Beatriz Seoane, Cristina Villarroel, Helena Pujol, Maria Jesus Bermejo, Ajay Aggarwal & Ioannis Psallidas  Respiratory Research volume 21, Article number: 211 (2020)  Abstract Background Navafenterol (AZD8871) is an inhaled long-acting dual-pharmacology muscarinic antagonist/β2-adrenoceptor…